UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000571
Receipt number R000000632
Scientific Title A randomized control study to see the effect of intensive treatment of hypertension and hyperlipidemia on patients having documented coronary artery disease.
Date of disclosure of the study information 2007/11/29
Last modified on 2016/03/03 09:37:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized control study to see the effect of intensive treatment of hypertension and hyperlipidemia on patients having documented coronary artery disease.

Acronym

JCADII(Japanese Coronary Artery Disease Study II)

Scientific Title

A randomized control study to see the effect of intensive treatment of hypertension and hyperlipidemia on patients having documented coronary artery disease.

Scientific Title:Acronym

JCADII(Japanese Coronary Artery Disease Study II)

Region

Japan


Condition

Condition

Patients diagnosed as having 75% or higher stenosis according to the AHA classification in at least one branch of the coronary artery with hypertension and hyperlipidemia.

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of the study is to see the outcome effect of intensive therapy of hyperlipidemia and hypertension on patients having definite coronary artery disease compared with conventional therapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Composite endpoint - all deaths, nonfatal MI/stroke/vascular/peripheral vessel events, unstable angina pectoris, all hospitalization and CABG
Evaluated three years after intervention started.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Intensive Therapy
Therapeutic Target
BP <120/80mmHg
LDL-C <80mg/dL

Interventions/Control_2

Conventional Therapy
Therapeutic Target
BP <140/90mmHg
LDL-C <100mg/dL

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

79 years-old >=

Gender

Male and Female

Key inclusion criteria

1) 20 years-old or older and less than 80 years-old
2) hyperlipidemia
3) hypertension
4) have 75% or more stenosis in at least one branch of the coronary arteries according to the AHA classification diagnosed by either CT or CAG
5) written informed consent to enter the study available

Key exclusion criteria

Patients are excluded from study inclusion if they have

1) allergy to test drugs
2) familial hypercholesterolemia
3) uncontrolled hyperlipidemia (LDL-C >= 180mg/dL)
4) uncontrolled hypertension (systolic blood pressure >= 180mmHg and/or diastolic blood pressure >= 110mmHg)
5) AMI and/or stroke within 3months before intervention
6) secondary hypertension
7) secondary hyperlipidemia
8) severe valvular disease including mitral stenosis or incompetence of the aortic valve
9) severe arrhythmia including ventricular fibrillation or ventricular tachyrhythmia
10) renal failure (serum creatinine >=2.5 mg/dL)
11) liver dysfunction (AST and/or ALT over three times the normal value)
12) pregnancy and/or possibility of pregnancy

or if the attending doctor disqaulifies the patients to be included in the study for whatever reason.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ryozo Nagai

Organization

Tokyo University Graduate School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code


Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-5800-6526

Email



Public contact

Name of contact person

1st name
Middle name
Last name Tsutomu Yamazaki

Organization

Tokyo University Graduate School of Medicine

Division name

Department of Clinical Epidemiology and Systems

Zip code


Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-5800-9844

Homepage URL


Email

heart-kenkyukai@umin.ac.jp


Sponsor or person

Institute

J-CADII study committee

Institute

Department

Personal name



Funding Source

Organization

Japan Heart Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 11 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2006 Year 10 Month 26 Day

Date of IRB


Anticipated trial start date

2006 Year 11 Month 01 Day

Last follow-up date

2010 Year 04 Month 01 Day

Date of closure to data entry

2010 Year 10 Month 01 Day

Date trial data considered complete

2011 Year 03 Month 01 Day

Date analysis concluded

2011 Year 06 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 01 Month 04 Day

Last modified on

2016 Year 03 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000632


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name